Zelluna Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Namir Hassan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureless than a year

Recent management updates

No updates

Recent updates


CEO

Namir Hassan

no data
Tenure

Mr. Namir Hassan Ph D., was Chief Executive Officer of Ultimovacs ASA. Mr. Hassan is Chief Executive Officer of Zelluna ASA since 2019 (Zelluna Immunotherapy AS).He joined the Zelluna Immunotherapy AS in...


Board Members

NamePositionTenureCompensationOwnership
Anders Tuv
Co-Founder & Chairmanless than a yearno datano data
Hans Robinson
Co-Founder & Non Executive Directorno datano datano data
Bent Jakobsen
Directorno datano datano data
Wolf Fridman
Member of Scientific Advisory Boardno datano datano data
Ulrike Köhl
Member of Scientific Advisory Boardno datano datano data
Dirk Jäger
Member of Scientific Advisory Boardno datano datano data
May Sabry
Member of Scientific Advisory Boardno datano datano data
Omid Hamid
Member of Scientific Advisory Boardno datano datano data
Michael Nishimura
Member of Scientific Advisory Boardno datano datano data
Eva-Lotta Allan
Directorless than a yearno datano data
Charlotte Sofie Berg-Svendsen
Directorless than a yearno datano data
0.2yrs
Average Tenure

Experienced Board: 7UM0's board of directors are not considered experienced ( 0.2 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/23 23:25
End of Day Share Price 2025/05/23 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zelluna ASA is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.